Neuroblastoma Treatment Cost in India

Find the best Neuroblastoma Treatment cost in India. Compare top hospitals, success rates and patient reviews.

Starting From

$500

Average Cost

$2,000

Up To

$6,000

What Is the Cost of Neuroblastoma in India?

Neuroblastoma treatment in India typically ranges from $500 to $6,000 USD, depending on the hospital, city, and type of procedure.

Key Factors That Influence the Cost

  • Type of Surgery: Surgical tumor resection and induction chemotherapy versus autologous stem cell transplant and anti-GD2 immunotherapy.
  • Location and Facility: Tier-1 private hospitals in major medical hubs like Delhi NCR, Mumbai, or Bengaluru generally charge higher rates than regional or specialized centers.
  • Hospital Stay: Length of time required in the Intensive Care Unit (ICU) and post-operative monitoring (Structured phased admissions: 5 to 7 days for surgery; 3 to 4 weeks for transplant).
  • Pre- and Post-Op Care: Diagnostic imaging (24-hour urine catecholamines (VMA/HVA), MIBG scintigraphy scan, abdominal/pelvic MRI, and bone marrow aspirate), medication, and follow-up consultations.
  • Implants and Consumables: Long-term central venous lines (Broviac/Port-a-Cath) and stem cell collection consumables.

Note: Final quotations must be confirmed with the hospital following a comprehensive review of your medical records.

Neuroblastoma Cost Comparison Across Different Cities in India

Treatment costs for Neuroblastoma remain highly competitive across India's premier medical hubs, including Delhi NCR, Mumbai, Chennai, Bengaluru, and Hyderabad.

Geographical cost variations between hospitals are driven by specific institutional and operational standards:

  • Hospital Accreditation: Tertiary and quaternary hospitals accredited by JCI and NABH maintain specialized infrastructure including dedicated operating theaters and intensive care units.
  • Surgeon & Specialist Standing: Senior Pediatric Oncologists and Pediatric Surgeons with high procedural volume and international training.
  • Technological Capabilities: Centers equipped with advanced diagnostic and surgical systems such as Long-term central venous lines (Broviac/Port-a-Cath) and stem cell collection consumables.
  • Local Living & Caregiver Expenses: Daily accommodation, transport, and food costs in metropolitan cities (higher in Mumbai and Delhi than in Chennai or Hyderabad).

Patients are advised to prioritize hospital accreditation and specialist expertise over minor cost differences between cities.

Our Services for Neuroblastoma Treatment in India

Transparent, professional support—without the hassles.

Book Doctor Appointment

Choose a specialist and schedule a convenient consultation.

Video or In-person Consultation

Consult remotely or meet your doctor directly at the hospital.

Compare Cost Estimates

Review transparent estimates from suitable hospitals.

Hospitalisation Support

Get coordinated assistance throughout your hospital stay.

WhatsApp Us

What Factors Affect the Cost of a Neuroblastoma?

The overall cost of managing Neuroblastoma in India varies according to patient-specific clinical requirements and procedural scope.

Key variables directly influencing the final treatment expenditure include:

  • Primary Clinical Approach: Induction chemotherapy, complete surgical tumor excision, autologous stem cell transplant, and anti-GD2 immunotherapy.
  • Pre-Treatment Staging & Investigations: 24-hour urine catecholamines (VMA/HVA), MIBG scintigraphy scan, abdominal/pelvic MRI, and bone marrow aspirate.
  • Surgical Implants & Technology: Use of specialized devices such as Long-term central venous lines (Broviac/Port-a-Cath) and stem cell collection consumables.
  • Hospitalization Duration: Length of time in the ICU and room selection (twin sharing vs. private single room).
  • Complication Risk Management: Potential clinical events requiring intervention, including Severe myelosuppression, immunotherapy neuropathic pain, capillary leak syndrome, and hearing loss.
  • Post-Procedure Rehabilitation: Comprehensive pediatric oncology follow-up across 12 to 18 months.

Hospitals provide an itemized fee breakdown following a thorough review of the patient's diagnostic imaging and medical dossier.

Why Choose India for Neuroblastoma Treatment?

India is a preferred destination for international patients seeking advanced, affordable clinical management for Neuroblastoma.

Key reasons to choose India for treatment include:

  • Expert Medical Specialists: Board-certified Pediatric Oncologists and Pediatric Surgeons with international fellowships and proven track records.
  • Internationally Accredited Hospitals: Facilities certified by JCI and NABH upholding strict safety, hygiene, and patient-care protocols.
  • State-of-the-Art Technology: Immediate access to advanced platforms including Long-term central venous lines (Broviac/Port-a-Cath) and stem cell collection consumables.
  • Substantial Cost Savings: Treatment delivered at 60% to 80% lower cost compared to the United States, UK, or private Middle Eastern centers.
  • Dedicated International Concierge: End-to-end support with medical visa invitation letters, language translators, airport pickups, and local stay arrangements.
  • Zero Waiting Times: Fast-track specialist consultations, immediate diagnostic workups, and prompt procedural scheduling.

Note: Individual treatment candidacy and anticipated outcomes must be confirmed directly through a specialist clinical evaluation.

Top Doctors in India

Recommended Doctors for Neuroblastoma Treatment

Top Hospitals in India

Recommended Hospitals for Neuroblastoma Treatment

Frequently Asked Questions Related to Neuroblastoma Treatment Cost in India

Neuroblastoma is a medical condition treated in India through tailored interventions led by Pediatric Oncologists and Pediatric Surgeons.

Main treatment approaches include:

  • Multi-Agent Induction Chemotherapy: Aggressive drug cycles to shrink primary retroperitoneal or adrenal tumors.
  • Radical Surgical Resection: Meticulous surgical removal of tumor separating it from major retroperitoneal vessels.
  • Anti-GD2 Immunotherapy & Transplant: Dinutuximab immunotherapy and autologous stem cell rescue for high-risk disease.

Need Assistance?Chat